Estrella Immunopharma, Inc. (ESLAW) Warrants
Each ESLAW warrant gives the holder the right to buy 1 share of Estrella Immunopharma, Inc. at $11.50 per share, until September 29, 2028. The stock last closed at $0.34, below the strike, so the warrant is out of the money. Estrella Immunopharma, Inc. has a market value of about $14.95M. There are 2.21M listed warrants; exercising all of them would add 5.0% to the 43.97M shares outstanding. The company can call the warrants if the stock trades at or above $16.50.
Estrella Immunopharma, Inc. reports its business to the SEC as “Biological Products, (No Diagnostic Substances)”, with its head office in Emeryville, CA. The ESLAW warrants were first issued by a SPAC and became Estrella Immunopharma, Inc. warrants when the merger closed on September 29, 2023. Its latest SEC filing was on November 16, 2026: quarterly report, form 10-Q. The warrant closed at $0.0612 on November 18, 2026, down 39% from $0.1000 on November 17, 2025. ESLA trades at 3% of the strike; it would have to rise about 34-fold to reach it.
Thinly traded: ESLAW traded about $287 a day over the last 30 days, and on only 10 of 22 trading days. With so little trading you may not be able to buy or sell near the price shown; use a limit order.
Key terms
- Strike per share
- $11.50
- Shares per warrant
- 1
- Cash to exercise one warrant
- $11.50
- Expiry
- 2028-09-29
- Redemption trigger
- $16.50
- Cashless exercise
- allowed
- Break-even stock price
- $11.56
From the issuer's S-1/A (2026-01-16).
Redemption risk Low
ESLA closed at or above $16.50 on 0 of the last 30 trading days. The company can call the warrants once it reaches 20, so 20 more days above the trigger would be enough.
- Trigger price
- $16.50
- Last close
- $0.34 (2% of trigger)
- Days at or above, last 30
- 0 (needs 20)
The usual rule: 20 closes at or above the trigger within 30 trading days, then 30 days' notice. Some companies use a different test; check the warrant agreement. Counted from daily closes up to 2026-11-20. Follow ESLAW to get an email when it gets close.
Exercise calculator
Each warrant buys 1 share at $11.50. Before expiry a warrant usually sells for more than its exercise value, because it still has time left. Fees and taxes are not included. Arithmetic, not investment advice.
Company and stock
- Company
- Estrella Immunopharma, Inc.
- Underlying stock
- ESLA
- Share price
- $0.34
- Market cap
- $14.95M
- Shares outstanding
- 43.97M
- 12-month range
- $0.31 – $2.12
- 12-month change
- -81%
- Value of all listed warrants
- $135.56K (0.9% of market cap)
- Industry
- Biological Products, (No Diagnostic Substances)
- Head office
- Emeryville, CA
Market cap is the last share price times shares outstanding (as of 2026-11-11). Industry and head office are as the company reports them to the SEC. All SEC filings for this company.
Model value Pro · free for now
The stock is at 3% of the strike; this far from it the answer is mostly a guess about volatility.
- Last price
- $0.0612
- Low and high estimate
- $0.0000 – $0.0036
- Stock volatility, measured
- 151% (stock under $1)
- Volatility we use
- 50% · 80% · 100%
- Volatility the price implies
- 157%
- Redemption trigger
- $16.50
- Effect of dilution
- −4.6%
- Method
- day-by-day tree with the redemption trigger
The estimate uses a volatility below the one measured, because measured volatility overstates what the market pays for. Not investment advice.
Dilution
- Shares outstanding
- 43.97M
- Listed warrants
- 2.21M
- Dilution if all exercised
- 5.0%
Warrant count from the text of the company's SEC filing.
Filings
- 10-QQuarterly report
- 8-KCurrent report: directors or officers changed; other events
- 8-KCurrent report: delisting notice Key
- 8-KCurrent report: delisting notice Key
- 10-QQuarterly report
- 8-KCurrent report: shareholder vote results
- DEF 14AProxy for a shareholder vote
- 10-QQuarterly report
- NT 10-QQuarterly report will be late
- 10-K/AAnnual report (amended)
The company's latest SEC filings, checked every night. Insider trades and routine SEC paperwork are left out. All SEC filings for this company.
Events
- Terms source: S-1/A
- Merger closed; the warrants became warrants of the combined company
Questions about ESLAW
When does the ESLAW warrant expire?
ESLAW expires on September 29, 2028.
What is the strike price of ESLAW?
$11.50 per share; each warrant converts into 1 share, so exercising one warrant costs $11.50.
Can Estrella Immunopharma, Inc. redeem the ESLAW warrants early?
Yes. The company can call them if the share price reaches $16.50 for the required period (usually 20 of 30 trading days).
How many ESLAW warrants are outstanding?
2.21M listed warrants, equal to 5.0% dilution if all are exercised.
Related warrants
Get an email when alerts open
Follow ESLAW with the button at the top to get its alerts. Alerts are coming soon; leave your email and we will tell you when they open.

